The purpose of this study is to determine whether sublingual buprenorphine is effective in the treatment of acute pain in adult patients with extremity bone fractures
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
80
0.4 mg, SL (sublingual) Buprenorphine PLUS 5 ml Placebo IV (in the vein)
Placebo SL PLUS 5 ml Morphine sulfate (1mg/ml) IV
Emergency Department, Imam Hospital
Tehran, Tehran Province, Iran
Change in pain severity/score
Time frame: After 60 min
Need for rescue analgesia
Time frame: After 60 min
Occurrence of adverse events
Time frame: During 60 min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.